Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

(2011) Douglas W. Losordo et al.   CIRCULATION RESEARCH

Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study

(2010) Antonio Maria Leone et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Ficoll-Paque™ versus Lymphoprep™: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations

(2009) Chia Yeo et al.   Regenerative Medicine

Efficiency of Intramyocardial Injections of Autologous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study

(2009) Evgeny Pokushalov et al.   Journal of Cardiovascular Translational Research

Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial

(2008) Chia Yeo et al.   Regenerative Medicine

Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone

(2008) Keng-Leong Ang et al.   Nature clinical practice. Cardiovascular medicine